BRANDON BOYD: Open Payments
NPI 1790430577 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 36 payments from 17 companies in 2025. Trend: 2023 $649 · 2024 $957 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $148 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| ABBVIE INC. | 4 | $67 |
| Lilly USA, LLC | 3 | $53 |
| Novo Nordisk Inc | 3 | $47 |
| Zimmer Biomet Holdings, Inc. | 1 | $38 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: Dexcom G6 Transmitter, JARDIANCE, AIRSUPRA, ROSA, QULIPTA, Wegovy, OTEZLA, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
